About Us
Tianjin Puli Ark Medical Technology Co., Ltd. (hereinafter referred to as "Puli Ark") is a wholly-owned subsidiary of Noah Medical Corp. (hereinafter referred to as "Noah") in China. Aiming to usher in a new era of medical robots with next-generation technology, we have launched the new generation of the Galaxy bronchoscope robot for early diagnosis and treatment of patients with corresponding indications.
About Us
Tianjin Puli Ark Medical Technology Co., Ltd. (hereinafter referred to as "Puli Ark") is a wholly-owned subsidiary of Noah Medical Corp. (hereinafter referred to as "Noah") in China. Aiming to usher in a new era of medical robots with next-generation technology, we have launched the new generation of the Galaxy bronchoscope robot for early diagnosis and treatment of patients with corresponding indications.
Puli BaiChuan System
The manufactured Bronchial Navigation and Positioning System, as a domestically produced bronchoscope robot with cutting-edge technology, utilizes 3D Imaging DT technology, which deeply integrates imaging capabilities, to help clinicians improve the accuracy of lesion arrival and the efficiency of diagnosis and treatment.
The manufactured Bronchial Navigation and Positioning System, as a domestically produced bronchoscope robot with cutting-edge technology, utilizes 3D Imaging DT technology, which deeply integrates imaging capabilities, to help clinicians improve the accuracy of lesion arrival and the efficiency of diagnosis and treatment.
News Center
-
The Puli Baichuan Bronchoscopy Robot Master Training Program Concludes Successfully – Discussing High-Precision Medicine and Empowering a New Future for Interventional Respiratory Care
On December 27, 2025, the "First Puli Baichuan Bronchoscopy Robot Master Training Course" was successfully held at the Panlongshan Campus of Shandong Public Health Clinical Center. This training course focused on the application of bronchoscopy robot technology in the field of interventional respiratory medicine.
View Details -
Clinical Update | The Prince of Wales Hospital of the Chinese University of Hong Kong, leveraging the Pribain bronchoscopy robot, pioneers a new paradigm of high-precision integrated diagnosis and tre
From March 3rd to 4th, 2026, Professor Calvin Ng's team at the Prince of Wales Hospital, Chinese University of Hong Kong, achieved a major clinical breakthrough: the team successfully used the Pribaby bronchoscopy robot to complete...
View Details -
A Comprehensive Guide to 3D Imaging (DT) Technology
Early detection, diagnosis, and intervention of pulmonary nodules are crucial for reducing the risk of lung cancer incidence and mortality and improving long-term survival rates. However, complex lesions and small lesions in the peripheral lung regions are often difficult to detect due to their deep location, small size, and proximity to adjacent structures.
View Details -
Disposable bronchoscopes: redefining the safety and efficiency of respiratory interventions, the clinician's "optimal solution" is here!
The Pribaichuan system, a robot-assisted bronchoscopy platform equipped with disposable bronchoscopes and related consumables, features easy installation and cleaning, reduced risk of cross-infection, and ensures that doctors and patients use brand-new, high-performance endoscopes for every surgery.
View Details -
The value divide in medical robots—why medical robot companies prioritize "clinical value"
This article serves as a preliminary study in Noah Medical's series of in-depth reports, aiming to help investors establish a core value judgment framework for the medical robotics industry. With the medical robotics sector continuing to heat up, market discussions often focus on...
View Details -
Noah Medical leverages technology to create integrated value in lung cancer diagnosis and treatment, breaking through existing limitations and opening up platform-based growth opportunities.
Source: Gelonghui In the field of medical technology investment, a growing consensus is that simply identifying significant unmet clinical needs is no longer sufficient to constitute a solid investment logic. The real watershed that determines a company's long-term value lies in whether it constitutes…
View Details
Marketing Activities
-
Hangzhou Jinsha Lake Conference Announcement PosterHangzhou Jinsha Lake Conference Announcement PosterView Details
-
Announcement Poster for the Eastern Respiratory Diseases Academic ConferenceAnnouncement Poster for the Eastern Respiratory Diseases Academic ConferenceView Details
-
Puli Ark made its debut at the 18th Ruijin Respiratory Diseases Academic ConferenceFrom May 23rd to 24th, 2026, the 18th Ruijin Respiratory Disease Academic Conference, hosted by the Beijing Association for the Promotion of Chronic Disease Prevention and Treatment of Integrated Traditional and Western Medicine, was successfully held at the Sheraton Shanghai Pudong Hotel. This conference included an "Artificial Intelligence Forum," bringing together…View Details
National unified contact hotline:
022-24892180
Address: 1st Floor, Building 6, Block B, No. 6 Huafeng Road, Huaming High-tech Industrial Zone, Dongli District, Tianjin
Copyright © Tianjin Puli Medical Technology Co., Ltd. All rights reserved.
